2269:HKG
WuXi Biologics (Cayman) Inc
HK$48.20
arrow_downward
-0.90%(-0.44) 1દિ
16 ઑક્ટો, 04:08:14 PM GMT+8 · HKD
search
બધા પ્રતીકો
| પ્રતીક | ભાવ | ફેરફાર | ફેરફાર %માં |
|---|
insights_auto2269 માટે મુખ્ય જાણકારીઓ જનરેટ કરી રહ્યાં છીએ...
ખોલો
HK$49.98
ઉચ્ચ
HK$50.85
ઓછો
HK$45.82
માર્કેટ કૅપિટલાઇઝેશન
1.98 નિખર્વ
સરેરાશ વૉલ્યૂમ
3.04 કરોડ
વૉલ્યૂમ
5.52 કરોડ
P/E ગુણોત્તર
34.48
52-અઠવાડિયામાં ઉચ્ચ
HK$58.00
52-અઠવાડિયામાં ન્યૂનતમ
HK$28.48
EPS
HK$1.40
બાકી રહેલા શેર
1.23 અબજ
કર્મચારીઓની સંખ્યા
15 હજાર
ખોલો
HK$49.98
ઉચ્ચ
HK$50.85
ઓછો
HK$45.82
માર્કેટ કૅપિટલાઇઝેશન
1.98 નિખર્વ
સરેરાશ વૉલ્યૂમ
3.04 કરોડ
વૉલ્યૂમ
5.52 કરોડ
P/E ગુણોત્તર
34.48
52-અઠવાડિયામાં ઉચ્ચ
HK$58.00
52-અઠવાડિયામાં ન્યૂનતમ
HK$28.48
EPS
HK$1.40
બાકી રહેલા શેર
1.23 અબજ
કર્મચારીઓની સંખ્યા
15 હજાર
ન્યૂઝ સ્ટોરી
વેબ સૉર્સ અને ન્યૂઝ પાર્ટનર તરફથી
Yahoo! Finance Canada
·
16 મિનિટ પહેલાં
NTHI,VITL,TRIN,HERZ,SRAD,EFOR,FFIN,AVBC,NXRT,BBSI,BLCO,CULP,VSNT,VIRC,GRNT,SSP,GAIA,CSPI,AFCG,AWRE,APCX,KLTR,AUBN,BETR | Stock Prices | Quote Comparison
The Motley Fool
·
6 મિનિટ પહેલાં
Should You Invest in the S&P 500 Right Now or Wait? There's 1 Clear Answer
Simply Wall Street
·
7 મિનિટ પહેલાં
Warner Music Group (WMG) Draws Fresh Interest, Is A 17% Discount Still On Offer?
Yahoo Finance
·
7 કલાક પહેલાં
Michael Burry Warns of a Stock Market ‘Supervolcano’
પ્રોફાઇલ
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
WuXi Biologics (Cayman) Inc વિશે